NeuroOne Medical Technologies
NMTC
20 hedge funds and large institutions have $1.34M invested in NeuroOne Medical Technologies in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.44% less ownership
Funds ownership: 1.31% → 0.87% (-0.44%)
5% less funds holding
Funds holding: 21 → 20 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
44% less capital invested
Capital invested by funds: $2.4M → $1.34M (-$1.06M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$68K |
| 2 |
Jane Street
New York
|
+$33.2K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$23.1K |
| 4 |
HF
HRT Financial
New York
|
+$10.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$791K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$149K |
| 3 |
VF
Virtu Financial
New York
|
-$10K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$6.55K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$858 |
NMTC Hedge Fund Activity: Q4 2024 in Review
20 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q4 2024, worth a combined $1.34M — down 44% from $2.4M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of NMTC and 4 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $68K. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $791K sold.
- 20 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q4 2024, down from 21 in Q3 2024.
- Funds reported $1.34M of NeuroOne Medical Technologies stock for Q4 2024, down 44% quarter-over-quarter.
- 4 funds opened new NeuroOne Medical Technologies positions in Q4 2024 and 5 closed out, a net change of -1 holder.
- The largest NeuroOne Medical Technologies buyer in Q4 2024 was Citadel Advisors, an estimated $68K added.
- The largest NeuroOne Medical Technologies seller in Q4 2024 was Nantahala Capital Management, an estimated $791K sold.
Based on aggregated 13F filings for Q4 2024.